Abstract
The purpose of the present study was to examine the effects of a long-acting calcium antagonist, amlodipine, on the development of cardiac remodeling. Dihydropyridine calcium antagonists have been used widely for many years in the treatment of hypertension and angina pectoris. It has been reported, however, that a prototype of dihydropyridines, nifedipine, does not reduce mortality of patients with ischemic heart disease, possibly because of reflex stimulation of the sympathetic nervous system. A calcium antagonist, amlodipine, has been reported to have potential benefits by virtue of a gradual onset of action and a long duration of effects. Amlodipine (8 mg/kg per day, once a day) or nifedipine (24 mg/kg per day, three times a day) was administered to spontaneously hypertensive 12-week-old rats for 12 weeks. Left ventricular wall thickness was measured by echocardiography, and relative amounts of myosin heavy chain isoforms were assessed by pyrophosphate gels. Expressions of "fetal type" genes and type 1 collagen gene were examined by Northern blot analysis. Amlodipine and nifedipine both markedly reduced systolic blood pressure. However, the decrease in systolic blood pressure caused by nifedipine continued for no more than 8...Continue Reading
References
Nov 1, 1978·Journal of Molecular and Cellular Cardiology·J F HohP T Hale
Jul 1, 1992·Clinical Pharmacology and Therapeutics·L DonatiG Heinen
Feb 1, 1992·American Journal of Hypertension·B DahlöfL Hansson
Mar 1, 1992·Japanese Circulation Journal·H NishimuraK Kawamura
May 25, 1991·European Journal of Pharmacology·O TerlandT Flatmark
Dec 1, 1990·Journal of Hypertension·P Lund-JohansenT Stray
May 31, 1990·The New England Journal of Medicine·D LevyW P Castelli
Dec 1, 1990·Hypertension·T J ChildsA S Mak
Jan 1, 1988·Journal of Cardiovascular Pharmacology·W G Nayler
Jan 1, 1988·Journal of Cardiovascular Pharmacology·D R AbernethyM D Lambert
Aug 1, 1988·The Journal of Clinical Investigation·M KurabayashiY Yazaki
Oct 1, 1988·Hypertension·R DonnellyJ L Reid
Oct 1, 1985·Kidney International·C MaroneP Weidmann
Aug 15, 1985·Biochemical and Biophysical Research Communications·T A GustafsonE Morkin
Jan 1, 1983·Cardiovascular Research·I Medugorac, R Jacob
Dec 4, 1984·Biochemistry·C GenoveseB Kream
Aug 1, 1984·The Journal of Clinical Investigation·H TsuchimochiY Yazaki
Jan 1, 1993·Annual Review of Physiology·I Komuro, Y Yazaki
Feb 9, 1996·The Journal of Biological Chemistry·T YamazakiY Yazaki
Oct 10, 1996·The New England Journal of Medicine·M PackerD L DeMets
Citations
May 19, 2010·Internal and Emergency Medicine·Alberto MilanFranco Veglio
Jun 23, 2011·Cardiovascular Toxicology·Bhulan Kumar SinghSyed Ehtaishamul Haque
Nov 3, 2001·Journal of the American College of Cardiology·N NishikawaM Hori
Apr 28, 2001·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·C A Mandarim-de-Lacerda, L M Pereira
Nov 24, 2004·Clinical and Experimental Hypertension : CHE·Sanae El BardaiNicole Morel
Dec 10, 2015·Journal of Ethnopharmacology·Bhulan Kumar SinghSyed Ehtaishamul Haque
Dec 3, 2015·Journal of Hypertension·Hye Hyun YooDong-Hyun Kim
Jun 9, 2004·Life Sciences·María A SevillaMaría J Montero
May 9, 2009·American Journal of Hypertension·Augustine KakouMichel E Safar
Jun 15, 2007·Journal of Hypertension·David DuguayDenis deBlois
Feb 1, 2002·Journal of Hypertension·Jasmina VaragicEdward D Frohlich
Feb 7, 2020·Journal of Hypertension·Julieta S Del MauroChristian Höcht
Nov 14, 1998·Journal of Hypertension·J KyselovicT Godfraind
Sep 20, 2000·Journal of Hypertension·G R DaltonA Levy
May 6, 2004·Journal of Hypertension·Peter KrenekMaurice Wibo
Jul 24, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Atsushi OginoHisayoshi Fujiwara
Nov 24, 1999·Pediatric Transplantation·D M SilversteinM S Polinsky
Mar 12, 2021·The Journal of Clinical Hypertension·Cesar A RomeroPhillip D Levy
Sep 26, 2000·Molecular Genetics and Metabolism·P J LijnenR H Fagard